BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burnouf T, Gathof B, Bloch EM, Bazin R, de Angelis V, Patidar GK, Rastvorceva RMG, Oreh A, Goel R, Rahimi-levene N, Hindawi S, Al-riyami AZ, So-osman C. Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins against SARS-CoV-2. Transfusion Medicine Reviews 2022. [DOI: 10.1016/j.tmrv.2022.06.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Belem WF, Liu CH, Hu YT, Burnouf T, Lin LT. Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2). Viruses 2022;14. [PMID: 36366517 DOI: 10.3390/v14112419] [Reference Citation Analysis]
2 Bloch EM, Sullivan DJ, Shoham S, Tobian AAR, Casadevall A, Gebo KA. The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox. mBio 2022;13:e0286222. [PMID: 36314809 DOI: 10.1128/mbio.02862-22] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]